Langerhans cell histiocytosis with <i>BRAF</i> p.N486_P490del or <i>MAP2K1</i> p.K57_G61del treated by the MEK inhibitor trametinibYoav H. Messinger, Michael K. Richards, Lane H. Miller et al.|Pediatric Blood & Cancer|2020Cited by 20
Langerhans Cell Histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del Treated by the MEK Inhibitor TrametinibYoav H. Messinger, Michael Richards, Bruce Bostrom et al.|Unknown|2020Cited by 2